Axis-Shield, CTT Settle Patent Dispute Over Homocysteine Assays

Law360, New York (April 29, 2005, 12:00 AM EDT) -- Anglo-Norwegian in-vitro diagnostics company Axis-Shield Plc has reached an out-of-court settlement with Competitive Technologies Inc. in their patent dispute over homocysteine test results.

Under the agreement, Axis-Shield had agreed to pay royalties governing past and future sales of homocysteine tests to CTT until patent expiry in 2007, CTT said.

The agreement covers the distributor sales of Axis-Shield labelled kits, together with the homocysteine kits sold by BioRad in the US.

The negotiated agreement between CTT and Axis-Shield includes payment for past homocysteine tests sold by Axis-Shield...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.